Healthcare/Biotech
Glenmark, Dr Reddy's recall products in US: USFDA
Indian drugmakers Glenmark and Dr Reddy's Laboratories are recalling products in the United States. Glenmark is recalling oral contraceptive medication due to failed impurities. Dr Reddy's Laboratories is recalling muscle relaxant medication due to out-of-specification results. These recalls are initiated by the US Food and Drug Administration. India has many USFDA-compliant plants outside the US.
- India develops first indigenously discovered antibiotic "Nafithromycin" effective against resistant respiratory infections
- Strides Founder raises Rs 1000 crore to refinance debt
- Biocon Biologics expands collaboration with Civica to supply affordable insulin in US
- Roche Vs Natco: Supreme Court clears decks for launch of Natco Pharma's Risdiplam generic in India
- Prerna launches CANTEL™: A MicroRNA-based blood test for breast cancer screening
- Indian firms explore localisation of pharma production in Russia
- US Senator raises alarm over poor-quality drug imports from India and China, seeks tougher FDA inspections
- India to force drugmakers to upgrade plants after fatal cough syrup crisis
- Marengo Asia acquires Gujarat-based Sunshine Global Hospitals
- Alchem International moves Delhi HC against single-judge order on ‘Alchem’ trademark
- Heart blockages, tumors, fractures: Now, you can see what’s wrong inside your body in 3D at this Delhi govt hospital
- Lords Mark Industries Ltd. secures US FDA Registration, reinforces India’s position in global healthcare manufacturing
Alchem International moves Delhi HC against single-judge order on ‘Alchem’ trademark
Heart blockages, tumors, fractures: Now, you can see what’s wrong inside your body in 3D at this Delhi govt hospital
Lords Mark Industries Ltd. secures US FDA Registration, reinforces India’s position in global healthcare manufacturing
Under the scanner, yet generic cough syrups hit shelves
Lilly's weight-loss pill shows better blood sugar control in late-stage trials
Centre plans new law for stricter quality checks and surveillance of drugs, medical devices, and cosmetics
Biotech
Prerna launches CANTEL™: A MicroRNA-based blood test for breast cancer screening- Panacea Biotec bags Rs 127 crore order for oral polio vaccines
- Panacea Biotec gets supply order from UNICEF for oral polio vaccines worth Rs 315 cr
- Highs & Lows: Could the microdosing of psychedelics be a key missing piece in the mental health jigsaw?
- Fermenta board approves sale of environmental solutions biz to subsidiary
Healthcare
Marengo Asia acquires Gujarat-based Sunshine Global Hospitals- Heart blockages, tumors, fractures: Now, you can see what’s wrong inside your body in 3D at this Delhi govt hospital
- Lords Mark Industries Ltd. secures US FDA Registration, reinforces India’s position in global healthcare manufacturing
- Cloudnine Hospitals leads race to acquire Apollo Cradle
- One in six bacterial infections globally resistant to antibiotics in 2023: WHO Report
Pharmaceuticals
Biocon Biologics expands collaboration with Civica to supply affordable insulin in US
Roche Vs Natco: Supreme Court clears decks for launch of Natco Pharma's Risdiplam generic in India
Indian firms explore localisation of pharma production in Russia
India to force drugmakers to upgrade plants after fatal cough syrup crisis
Must Watch
BACK TO TOP